FDA Inspection
Brian S. Biesman, M.D.Brian S. Biesman, M.D. – FDA Inspection, Oct 14, 2025
Record Details
This FDA Inspection record concerns Brian S. Biesman, M.D., with an inspection on October 14, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · b46f4818-f0bf-4bb5-8e09-ea00e5ad13ad
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1286902
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Brian S. Biesman, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 31, 2023 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| November 7, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| October 5, 2015 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Brian S. Biesman, M.D.
- FDA Inspection 1217719 - 2023-08-31
- FDA Inspection 1073591 - 2018-11-07
- FDA Inspection 944905 - 2015-10-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.